CannabisNewsBreaks – CWCBExpo New York to Showcase Industry Leaders, Dynamic Solutions for Entire Cannabis Ecosystem

CWCBExpo New York today announced details for its upcoming event to take place Nov. 4-6, 2021, at the Javits Center in New York City. According to the update, the recently appointed chair of New York’s Cannabis Control Board, Tremaine Wright, will make her first public presentation at CWCBExpo New York on Nov 4. In addition, on behalf of New York’s Governor Kathy Hochul, Lieutenant Governor Brian A. Benjamin will officially open CWCBExpo New York at its Nov. 4 “Ribbon Cutting Ceremony.” Also in attendance all three days at CWCBExpo New York will be members of the New York State Office of Cannabis Management whose goal is to ensure social justice, public health and safety, and economic development through a comprehensive regulatory framework that centralizes licensing, enforcement and economic development functions. CWCBExpo will provide insight and education on New York’s and the tri-state region’s multifaceted and fast-developing cannabis industry and will feature innovative product, service and technology companies showcasing their solutions for the entire cannabis ecosystem.

To view the full press release, visit https://cnw.fm/Z0VNg

About Cannabis World Congress & Business Exposition

CWCBExpo is a business-to-business trade show event for the legalized cannabis and hemp industry. It is held in the largest business, financial and media markets. It is the leading forum for dispensary owners, growers, suppliers, investors, medical professionals, government regulators, legal counsel, and entrepreneurs looking to achieve business success and identify new areas of growth in this dynamic and fast-growing industry. For more information, visit www.CWCBExpo.com.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) on Target to Become House of Brands, Great Channel Partner

Red White & Bloom Brands (CSE: RWB) (OTCQX: RWBYF) recently welcomed former U.S. Congressman and now public policy consultant Ryan Costello to its board of directors. Costello is expected to deepen RWB’s U.S.-based representation, which is key as federal policy on cannabis shifts. The company also announced that it has built a new production facility to good manufacturing practice (“GMP”) specifications in Florida as part of an effort to capitalize on the growing cannabis derivative market there. The Florida facility is built to accommodate the demand for edibles. “Red White & Bloom has built a branded capsule and rosin line as well as a proprietary line of chocolates that the company expects to have out to medical patients by the end of the year,” reads a recent article. RWB also recently received adult recreational use prequalification status in Michigan. Speaking following the announcement, RWB chairman and CEO Brad Rogers notes, “This now provides a clear path for us to fully execute our strategy of being the house of brands and being great channel partners to all of our distribution points as well as our own planned flagship locations.”

To view the full article, visit https://cnw.fm/kGUwS

About Red White & Bloom Brands Inc.

The company is positioning itself to be one of the top three multistate cannabis operators active in the U.S. legal cannabis and hemp sector. RWB is predominantly focusing its investments on the major U.S. markets, including Michigan, Illinois, Florida, Massachusetts, Arizona and California with respect to cannabis, and the U.S. and internationally for hemp-based CBD products. For more information about the company, visit www.RedWhiteBloom.com.

NOTE TO INVESTORS: The latest news and updates relating to RWBYF are available in the company’s newsroom at https://cnw.fm/RWBYF

About CannabisNewsWire

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — Real Estate Survey Shows Proximity to Marijuana Firms Is Attractive

In just a few short years, marijuana reform legislation has had a major impact. The nascent industry has created thousands of new jobs, generated billions of dollars in revenue and filled state coffers with millions in tax money. With every passing day, attitudes on the controversial plant are evolving and changing, undoing the damage done by decades of federal prohibition little by little.

That was very evident when most states with legal cannabis markets declared it essential and went to great lengths to ensure people still had access to their medical marijuana, especially immunocompromised individuals who had no choice but to self-isolate. Now, a new survey has uncovered that a portion of Americans find homes in legal states with proximity to cannabis businesses to be more attractive compared to those with no access to cannabis.

Published by real estate company Redfin, the study found that almost one-half of Americans, 46% to be exact, would prefer to live in locations that allowed cannabis rather than those that criminalized the drug. The survey involved 1,023 U.S. residents who had moved into a new home in the past 18 months. Of the 46% who preferred locations with cannabis access, 34% wanted to live in such locations while 12% said that they would only live where cannabis was legal.

However, legal marijuana was not an attraction for everyone, with 22% of the respondents preferring to live in places that still prohibited cannabis. Of these individuals, 10% were certain that they would never live in a place that allowed cannabis while the remaining 12% preferred to live in such locations but could probably be swayed by other factors.

A reported 32% of the respondents did not care either way and would not use cannabis legality to decide where they would live. Taylor Marr, Redfin’s deputy chief economist, says that while people will consider the politics of a place when deciding where to move, factors such as affordability, easy access to jobs and proximity to schools often take precedence.

Still, this survey joins a growing body of research showing that cannabis can have a positive impact on real estate values. An analysis from Clever Real Estate that leveraged data from online real estate marketplace Zillow revealed that marijuana policies were often associated with higher home property values, with legal cannabis states seeing home values increase by $6,338. This is partly because the tax revenue generated from cannabis sales can be invested in the community and used to develop infrastructure and public services.

As time goes by, science is likely to reveal even more economic and other benefits that come from having marijuana firms such as Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) being allowed to operate legally not just at state level but federally.

NOTE TO INVESTORS: The latest news and updates relating to Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) are available in the company’s newsroom at https://cnw.fm/RWBYF

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — FDA to Use Reddit to Gather Information on CBD, Other Cannabinoids

The Food and Drug Administration (“FDA”) recently announced that it planned to use different sources of data such as Reddit to better understand public health issues surrounding the use of cannabis derivatives, including delta-8 THC and CBD. In its published report, the FDA explained that it needed information about the potential adverse events and safety issues associated with FDA-regulated products, which include cannabis-derived products, commonly referred to as CDPs.

The agency also revealed that it needed data on the general patterns of emerging trends and product use so that it could deploy its limited resources effectively and quickly. This comes at a time when the CDP market is growing at a rapid pace, significantly outpacing the advancements made in science.

The agency believes that new approaches to identifying safety signals using rigorous analytical methods and different data sources will significantly contribute to the agency’s ability to respond to rapidly evolving product areas such as the cannabis-derived products market. The FDA also revealed that there are a series of projects in its feasibility assessment phase, one of which involves viewing consumer-generated content such as Reddit posts in order to determine issues that aren’t easily captured through conventional systems.

A separate project would entail comparing CBD product samples from the FDA database with certificates of analysis, in order to identify any issues with quality or inconsistencies. In addition to this, the FDA plans to develop a system that will find usage patterns and safety signals linked to emerging cannabis-derived products in real time. This includes a cannabinoid known as delta-8 THC, which the FDA warned people about because the agency has not yet evaluated the effectiveness or safety of the substance.

Other compounds the FDA is interested in learning more about include CBG (cannabigerol), THCV (tetrahydrocannabivarin), CBN (cannabinol) and delta-10 THC (delta-10 tetrahydrocannabinol).

At the start of this year, the FDA had announced that it would be taking the necessary steps required to fill the gaps in research on the effectiveness and safety of CBD. The agency explained that it was focused on improving CBD product identification, helping to develop a consumer register for CBD products, increasing product sampling in relation to reports of adverse effects, and assessing the best strategies for quality monitoring and safety of different types of CBD products.

In 2020, the agency released draft guidelines to streamline approvals for generic CBD medications. The FDA was also mandated under the appropriations bill to present an update on its regulatory approach to CBD. It provided the update in March 2020.

It would benefit the entire cannabis industry including sector actors such as BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) if such data collection results in clear regulatory guidelines for the CBD market and other related sectors.

NOTE TO INVESTORS: The latest news and updates relating to BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) are available in the company’s newsroom at http://cnw.fm/BVNNF

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Green Hygienics Holdings Inc. (GRYN) Eyes Expansion, Stands to Benefit from Recently Signed AB45

Green Hygienics Holdings (OTCQB: GRYN), an enterprise focused on the high-standard cultivation and processing of industrial hemp, is one company expected to gain from the newly signed Assembly Bill 45 (“AB45”), which is set to benefit companies that grow and produce industrial hemp. AB45 allows for hemp-derived cannabinoids, extracts and derivatives in food and dietary supplements. “The company grows its hemp in a controlled environment at its farm in California, which, with 824 acres and 392,000 square feet of greenhouse space, is the largest USDA Certified Organic Hemp for CBD farm in North America,” reads a recent article. “The company will soon manufacture pharmaceutical-grade bioactive cannabinoids and other active ingredients that can be used for multiple applications in various sectors such as the pharmaceutical, nutraceutical and skin care industries. Green Hygienics is registered with the FDA and was granted USDA Organic Certification in 2020. Products available from the company are currently found in the U.S. and will be in the international markets soon.”

To view the full article, visit https://cnw.fm/7v5cu

About Green Hygienics Holdings Inc.

Green Hygienics Holdings is a California-based, innovative, technology-driven enterprise focused on the high-standard cultivation and processing of industrial hemp and manufacturing of pharmaceutical-grade bioactive cannabinoids. The company’s corporate mission is to adhere to the highest standards of operations in consistently delivering safe and premium-quality products to consumers as well as to partner with CPG (consumer packaged goods) and pharmaceutical companies. Hygienics is the science of preserving and promoting the health of individuals, communities and the planet. For more information about the company, visit www.GreenHygienics.com.

NOTE TO INVESTORS: The latest news and updates relating to GRYN are available in the company’s newsroom at http://cnw.fm/GRYN

About CannabisNewsWire

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Hero Technologies Inc. (HENC) Continues to Position Itself as Multistate Operator in Cannabis Sector

Hero Technologies (OTC: HENC) is focused on becoming fully licensed in Michigan as part of its ongoing commitment to position itself as a multistate operator in the cannabis sector. Its BlackBox Systems and Technologies LLC subsidiary fulfilled the requirements for step 1 prequalification approval for a Class C Medicinal Use cannabis license in Michigan and received step 1 prequalification approval for a Class C Adult-Use cannabis license. “With those approvals in hand, Hero Technologies and BlackBox are now beginning the next — and last — step in the process of obtaining licensing approval in Michigan: establishment use or full license approval for a newly constructed medical marijuana facility, which will allow HENC to move forward with its plans for cultivation of cannabis in Michigan,” reads a recent article. “In addition to its Michigan expansion plans, Hero Technologies is undertaking expansion in Colorado through its wholly owned subsidiary Mile High Green LLC… HENC is also planning to expand in Massachusetts through its wholly owned subsidiary MassCannabis LLC. In addition, Hero Technologies owns and operates two hemp websites: HighlyRelaxing.com under Highly Relaxing LLC and VeteranHempCo.com.”

To view the full article, visit https://cnw.fm/8F6gr

About Hero Technologies Inc.

Hero Technologies is a cannabis company working toward a vertically integrated business model. The company owns a majority stake in BlackBox Systems and Technologies LLC, an aeroponic cannabis cultivation system that provides optimal growing conditions to enhance photosynthesis and cultivation of large flowering plants, creating increased harvest efficiencies. Hero Technologies’ strategic business plan includes cannabis genetic engineering, farmland for both medical and recreational cannabis cultivation, production licenses, distribution licenses, consumer packaging, and retail and dispensary operations that make the company a multi-state operator (“MSO”). For more information about the company, visit www.HeroTechnologiesInc.com.

NOTE TO INVESTORS: The latest news and updates relating to HENC are available in the company’s newsroom at https://cnw.fm/HENC

About CannabisNewsWire

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Earns Coverage for DehydraTECH(TM)’s Potential Market Reach, Multiple Uses

Lexaria Bioscience Corp. (NASDAQ: LEXX) was recently part of coverage by Zacks Small-Cap Research analysts based on its market potential. Zacks, which focuses its coverage on small and micro-cap companies it regards as under-followed or under-valued by the broader market in an effort to benefit investors as well as worthy innovators, valued the company at $15 per share. The valuation was based on the company’s portfolio supporting Lexaria’s patented DehydraTECH(TM) consumption and the multiple potential uses of the technology. The technology is also relatively low-cost, with the capacity to produce up to 400,000 consumer packaged goods through existing manufacturer relationships. A recent article reads, “Zacks notes the potential market reach of Lexaria’s technology if regulatory approved for use in pharmaceuticals, given that hypertension affects about 150 million people nationwide and over a billion worldwide, many of whom find existing medicines less than optimal. The ongoing COVID pandemic has also heightened attention on the need for antivirals to treat ever-present virus infections. And there are about a billion smokers worldwide who could potentially benefit from alternative methods of delivering nicotine to avoid the lung-deleterious effects of inhaling burned or vaporized substances.”

To view the full article, visit https://cnw.fm/c2KFS

About Lexaria Bioscience Corp.

Lexaria Bioscience Corp.’s patented drug delivery technology, DehydraTECH(TM), improves the way active pharmaceutical ingredients (“APIs”) enter the bloodstream by promoting more effective oral delivery. Since 2016, DehydraTECH has repeatedly demonstrated the ability to increase bio-absorption with cannabinoids and nicotine by up to 5-10x, reduce time of onset from 1-2 hours to minutes and mask unwanted tastes; it is also being evaluated for orally administered anti-viral drugs, non-steroidal anti-inflammatory drugs (“NSAIDs”) and more. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood brain barrier. Lexaria operates a licensed in-house research laboratory and holds a robust intellectual property portfolio with 21 patents granted and over 50 patents pending worldwide. For more information, visit the company’s website at www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://cnw.fm/LEXX

About CannabisNewsWire

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Sprout AI Inc. (CSE: SPRT) to Provide Cultivation Services for Company Offering Plant-Based Medical Products

Sprout AI(CSE: SPRT), a technologically focused, sustainable vertical farming company that has developed scalable, AI-controlled aeroponic cultivation habitats, will be providing cultivation services for JT Medical. JT Medical has announced that it is accepting memorandums of understanding (“MOUs”) from researchers looking to obtain high-quality, repeatable batch, plant-based medical products derived from regulated plants. The company noted that those plants may include cannabis, psilocybin mushroom and peyote. In the announcement, JT Medical said that SPRT provides self-contained habitats used in the process of producing its high-quality, repeatable batches. The habitats provide control of variables that impact crop duplication. JT Medical explained that the Sprout AI habitats will be operated via One System One Solution enterprise resource planning and compliance (“ERPc”) software. This process provides key information to researchers that enable them to track batches from seed, clone or tissue sample through to the final use or product. “Sprout AI habitats are used to ensure the replication of active medicinal plant ingredients as well as terpene, flavonoids and other desired components,” the company stated in the press release. “This enables both short-, mid- and long-term studies are derived from the ‘same’ product for medical research and efficacy reports.”

To view the full press release, visit https://cnw.fm/ynnQJ

About Sprout AI Inc.

Sprout AI is a vertical farming technology company in the business of planning, designing, manufacturing and/or assembling sustainable and scalable AI-controlled vertical cultivation equipment for indoor vertical farming. The adaptive technology produces an environment with improved growing parameters and early detection of adverse conditions, resulting in consistent and repeatable crops with shorter cultivation cycles, independent of geographic climates. The self-contained multilevel rolling rack technology increases the cubic cultivation area while mitigating the risk of outside and cross-contaminants. For more information about the company, visit www.SproutAI.solutions.

About CannabisNewsWire

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — Top IRS Official Reveals Cannabis Banking Reform Can Ease Tax Organization’s Work

Marijuana businesses have been unable to access financial services such as deposit accounts, cashless payments and loans since legal sales began in America. This is mostly due to the controversial plant’s classification as a Schedule I controlled drug, and it has had wide-ranging consequences on both cannabis businesses and federal authorities.

Players in the cannabis space are forced to transact on a cash-only basis, increasing their chances of robberies and making it difficult to account for and pay taxes. Furthermore, federal authorities, the IRS specifically, don’t often receive taxes that are due, and when they do, it is usually in large amounts of cash.

For quite a while, stakeholders, drug reform activists and lawmakers have urged federal authorities to allow cannabis businesses to access banking services. Recently, a top IRS official joined the growing number of figures that support banking services for America’s state-legal cannabis industry after she claimed that cannabis banking reform would ease the taxman’s work.

The IRS would like to get paid, IRS official Cassidy Collins said during an event hosted by UCLA’s Annual Tax Controversy Institute, and granting marijuana access to the banking system will be a big help. As it stands, marijuana presents a “special type of collection challenge” since the plant is federally outlawed and mostly stuck to cash-only payments that make it harder for the federal agency to receive taxes from cannabis businesses, Cassidy says.

She notes that the cash-only payment crisis can be attributed to two things: customers that are avoiding a paper trail that shows they purchased cannabis and banks that avoid working with cannabis businesses due to fear of reprisal by the federal government. Fortunately, lawmakers have introduced cannabis reform bills to give the industry access to banking services, and one of them has made headway.

Cassidy, a senior counsel in the IRS Office of Chief Counsel, says that while her views on cannabis banking may not represent the IRS’s or her own opinion, it would make the agency’s job of collecting taxes a lot easier. The Internal Revenue Service’s main objective, after all, is to collect taxes, and any legislation that eases the agency’s efforts is welcome.

Currently, cannabis business operators have to visit IRS tax assistance centers, which accept cash payments greater than $50,000. However, Cassidy notes that an operator will likely spend some time at the center because the federal employee has to check and double-check payments. The agency wants to work with companies in the cannabis space, regardless of the plant’s status with the federal government, to ensure it gets paid the taxes owed. Should lawmakers finally pass cannabis legislation, both cannabis companies and the IRS stand to benefit.

Cannabis banking reform will not only benefit the IRS but will also remove a major bottleneck faced by the entire marijuana industry, including sector players such as Hero Technologies Inc. (OTC: HENC).

NOTE TO INVESTORS: The latest news and updates relating to Hero Technologies Inc. (OTC: HENC) are available in the company’s newsroom at https://cnw.fm/HENC

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — New Measure Will Give Scientists Access to Marijuana Dispensary Products

Last week, a group of federal legislators introduced the Medical Marijuana Research Act, which will eliminate barriers to carrying out research on cannabis. It will include permitting researchers to access marijuana from state-legal dispensaries. The measure was filed by Rep. Andy Harris, a prohibitionist, and Rep. Earl Blumenauer, a pro-legalization lawmaker. The bill will streamline the process for scientists to apply and gain approval to conduct research on marijuana.

In a recent interview, Blumenauer stated that federal legislations were still constraining researchers’ ability to study the various health benefits provided by marijuana, despite the fact that a majority of individuals in America are living in a state that has legalized some form of marijuana.

In late 2020, the House passed a similar version of the marijuana science measure. The Medical Marijuana Research Act, which was filed with support from half a dozen other cosponsors, will also make it easier for researchers to alter their research protocols without seeking federal approval. It would also mandate that the DEA license more cultivators and remove the limit on the number of organizations that can register to grow cannabis for research purposes.

In addition, it would also require that the Department of Health and Human Services present a report that offers an overview of the results of federal marijuana studies to Congress. Furthermore, it would remove additional layers of protocol review, minimize the number of costly security requirements and decrease approval wait times.

In his Congressional Record remarks, Blumenauer stated that the marijuana laws in the United States were broken, including the laws which govern research on marijuana. He explained that since marijuana was still classified as a Schedule I substance, scientists have to comply with strenuous requirements and jump through hoops just to conduct basic research on cannabis’ medical potential.

A Schedule I substance under the Controlled Substances Act refers to drugs that aren’t approved for medical use because they have a high potential for abuse. Blumenauer asserted that expanded research would ensure that Americans had adequate access to transformative treatments and medicines. For about 50 years now, scientists have only been able to conduct research on cannabis grown at the sole federally approved facility located at the University of Mississippi.

In related news, the DEA proposed a significant increase in the amount of cannabis and psychedelics such as mescaline, MDMA, LSD and psilocybin that it wants to be produced in the country for research purposes in 2022. This is after it announced in May that it would soon begin licensing new marijuana growers.

It would be interesting to see how the era of scientists legally using dispensary-sourced cannabis products will pan out when those researchers make use of state-of-the-art dose-measuring devices such as those manufactured by RYAH Group Inc. (CSE: RYAH).

NOTE TO INVESTORS: The latest news and updates relating to RYAH Group Inc. (CSE: RYAH) are available in the company’s newsroom at https://cnw.fm/RYAH

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.